Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT03762018 |
Title | BEAT-meso: Bevacizumab and Atezolizumab in Malignant Pleural Mesothelioma (BEAT-meso) |
Acronym | BEAT-meso |
Recruitment | Active, not recruiting |
Gender | both |
Phase | Phase III |
Variant Requirements | No |
Sponsors | European Thoracic Oncology Platform |
Indications | |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | ITA | GBR | FRA | ESP | CHE | BEL |